Currently, aggressive B-cell lymphomas with a combined MYC- and BCL2 and/or BCL6 translocations (so-called double-hit or triple-hit, DH/TH lymphomas) are classified as a separate entity, irrespective of morphological features. The gene discussed is BCL2; the disease is lymphoma.